Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Tuberculosis (Edinburgh, Scotland)|November 26, 2010
The devil's advocacy: when and why inhaled therapies for tuberculosis may not workAwadh Bihari Yadav, Amit K Singh, Rahul K Verma, et al.
Biotechnology and Applied Biochemistry|August 14, 2025
Computational Drug Repositioning for Targeting PfEMP1: Potential Therapeutics for Cerebral Malaria in Plasmodium falciparumKanika Verma, Kavita Patel, Ankit Yadav, et al.
Journal of Vector Borne Diseases|June 26, 2024
Time to implement tailored interventions in Chhattisgarh, east-central India to reach malaria eliminationRitesh Ranjha, Sontee, Chander Prakash Yadav, et al.
Molecular Pharmaceutics|September 18, 2012
Inhalable microparticles containing nitric oxide donors: saying NO to intracellular Mycobacterium tuberculosisRahul K Verma, Amit K Singh, Mradul Mohan, et al.
Tuberculosis (Edinburgh, Scotland)|April 9, 2013
Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosisRahul Kumar Verma, Atul Kumar Agrawal, Amit Kumar Singh, et al.
Indian Journal of Experimental Biology|July 29, 2009
Inhalable microparticles containing isoniazid and rifabutin target macrophages and 'stimulate the phagocyte' to achieve high efficacyAwadh Bihari Yadav, Rolee Sharma, Pavan Muttil, et al.
Discover Nano|June 1, 2026
Ligand decorated nanostructure carrier systems for targeted delivery of antimalarialsKuldeep Singh, Ritesh Ranjha, Waseem Akram Malla, et al.
Tuberculosis (Edinburgh, Scotland)|April 13, 2010
Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosisAwadh B Yadav, Pavan Muttil, Amit K Singh, et al.
Antimicrobial Agents and Chemotherapy|November 28, 2012
Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in miceRahul Kumar Verma, Willem A Germishuizen, M Portia Motheo, et al.
Tuberculosis (Edinburgh, Scotland)|April 29, 2021
Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one monthAmit K Singh, Rahul K Verma, Jatinder Kaur Mukker, et al.
Pageof 2